Families, Responsibility, Education, Support, and Health for Executive Function

Description

The pilot study will be a one group open-label treatment program and will be used to refine a parent-based behavioral treatment enhanced with executive-function training (PBT-EF) for children with comorbid overweight or obesity and Attention-Deficit Hyperactivity Disorder (ADHD).

Conditions

Overweight and Obesity, Attention-Deficit Hyperactivity Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

The pilot study will be a one group open-label treatment program and will be used to refine a parent-based behavioral treatment enhanced with executive-function training (PBT-EF) for children with comorbid overweight or obesity and Attention-Deficit Hyperactivity Disorder (ADHD).

Executive Function Enhanced Parent-Based Treatment for Children With ADHD and Overweight or Obesity

Families, Responsibility, Education, Support, and Health for Executive Function

Condition
Overweight and Obesity
Intervention / Treatment

-

Contacts and Locations

San Diego

UCSD Center for Healthy Eating and Activity Research (CHEAR), San Diego, California, United States, 92037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Child with overweight or obesity (85-99.9% BMI for age),
  • * Child age 8-12,
  • * Child with a diagnosis of ADHD,
  • * A parent willing to participate who can read and understand English at a minimum of a fifth-grade level, able to attend treatment sessions remotely via Zoom on video.
  • * Current enrollment in an organized weight control program (parent and child)
  • * Medication specifically prescribed for weight loss (child)
  • * Medical or psychiatric condition that may interfere with treatment participation or that may require physician monitoring of diet and/or exercise (e.g., acute suicidality; psychosis; substance use disorder) (parent and child)
  • * Change in psychotropic medication or other medication that may impact weight or ADHD symptoms during the previous 3 months (child)

Ages Eligible for Study

8 Years to 12 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Diego,

Dawn M Eichen, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

2024-12